GENE ONLINE|News &
Opinion
Blog

2019-12-31| M&ASpecial

GeneOnline’s Top Mergers and Acquisitions of 2019

by Rajaneesh K. Gopinath
Share To
2019 was a year replete with major pharma, biotech, and digital healthcare deals. Here we highlight some of the major mergers and acquisitions of the year.

The year 2019 began with the big news of Bristol-Myers Squibb (BMS) agreeing to acquire Celgene Corporation for a value of about US$ 74 billion.According to data compiled by Refinitiv,

GO Prime with only $1.49 now

LATEST
New Regulatory Measures in China A First in the Fight Against Sedentary Behavior in Children
2024-05-24
Cure Genetics Announced Promising Safety and Efficacy Data of CAR-NKT Product CGC729 for RCC at ASGCT 2024
2024-05-23
AstraZeneca’s $1.5 Billion ADC Manufacturing Facility in Singapore
2024-05-23
Hims & Hers Health Inc. Tipping the Scales of the Weight Loss Market — and Wall Street is Loving it!
2024-05-22
GV Announces Cooperation with CICC
2024-05-22
Eli Lilly and Aktis Oncology Partner to Advance Novel Radiopharmaceuticals
2024-05-22
Preventive Medicine for Neurodegeneration on the Rise: New Breakthrough in Routine Blood Testing for Alzheimer’s Disease
2024-05-20
EVENT
Scroll to Top